Definitive Healthcare Q2 prelim revenue $63.7M (+5% YoY), goodwill impairment $363.6M; CRO resigns

Definitive Healthcare Corp.

Revenue $63.7M (+5% YoY); adjusted EBITDA $20.9M (33% margin) vs $17.2M (28%) YoY.
Net loss $(306.2)M ($(1.81)/share) includes $363.6M goodwill impairment; adjusted net income $0.09/share.
FY2024 guidance: revenue $247-251M, adjusted EBITDA $74-77M (30-31% margin), adjusted EPS $0.32-0.34.
CRO Carrie Lazorchak resigns effective Aug 2, 2024; sales organization reports to CEO Kevin Coop.
Adjusted operating income $19.3M vs $16.0M YoY, up 20.5%.

item 2.02 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Carrie Lazorchak

Chief Revenue Officer

DH · Definitive Healthcare Corp.

Effective: 2024-08-02
Filed: July 30, 2024, 7:59 PM ET

On July 24, 2024, Carrie Lazorchak, the Chief Revenue Officer of the Company, provided the Company with notice of her resignation, effective August 2, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Carrie Lazorchak resigned as Chief Revenue Officer at Definitive Healthcare Corp..

Action: resigned
Role: Chief Revenue Officer

Exact text from the filing

On July 24, 2024, Carrie Lazorchak, the Chief Revenue Officer of the Company, provided the Company with notice of her resignation, effective August 2, 2024.

View on SEC.gov

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR

accession 0000950170-24-087900

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.